TrialCancer2015

5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial.

Nina D Wagner-Johnston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.